Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced the realignment of its business structure aimed at building a stronger, more sustainable ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE